Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Lee Jackson | Jul 14, 2015 at 10:20 AM EDT

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…

Chris Lange | Jul 13, 2015 at 8:05 AM EDT

Short Sellers Run for Cover in Big Pharma

The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…

Paul Ausick | Jul 9, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the DJIA on Thursday

thinkstockJuly 9, 2015: Markets opened higher on Thursday and that’s when the major indexes posted their daily highs. New claims…

Lee Jackson | Jul 8, 2015 at 8:55 AM EDT

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay…

Paul Ausick | Jul 7, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow on Tuesday

thinkstockJuly 7, 2015: Markets opened slightly higher on Tuesday but a reversal took just moments to set in and U.S.…

Chris Lange | Jun 26, 2015 at 11:35 AM EDT

Is Big Pharma Advertising Getting Out of Control?

How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?

Chris Lange | Jun 25, 2015 at 8:10 AM EDT

Short Sellers Become More Focused on Big Pharma

The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Chris Lange | Jun 10, 2015 at 8:30 AM EDT

Short Sellers Back Off Big Pharma

The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Jun 8, 2015 at 1:00 PM EDT

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical…

Jon C. Ogg | Jun 7, 2015 at 9:40 AM EDT

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more…

Lee Jackson | May 28, 2015 at 10:20 AM EDT

3 Top Value Stock Picks to Buy for This Week

Investors looking to move down in volatility but stay fully invested may want to consider moving capital to any of…

Chris Lange | May 28, 2015 at 9:30 AM EDT

Short Sellers More Selective on Big Pharma Stocks

The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short…

Lee Jackson | May 22, 2015 at 9:15 AM EDT

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug…

Paul Ausick | May 13, 2015 at 4:01 PM EDT

The 4 Stocks That Drove the DJIA Down on Wednesday

thinkstockMay 13, 2015: Markets opened higher on Wednesday but were able to eke out just modest gains by the end…

1 … 57 58 59 60 61 … 98

Pfizer : PFE

All Pfizer Articles

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

The 4 Stocks That Boosted the DJIA on Thursday

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

The 4 Stocks That Boosted the Dow on Tuesday

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

3 Top Value Stock Picks to Buy for This Week

Short Sellers More Selective on Big Pharma Stocks

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Pfizer : PFE

All Pfizer Articles

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

3 Top Big Pharmaceutical Stocks With Upcoming Catalysts

Short Sellers Run for Cover in Big Pharma

The 4 Stocks That Boosted the DJIA on Thursday

3 UBS Must-Own Large-Cap Pharmaceutical Stocks

The 4 Stocks That Boosted the Dow on Tuesday

Is Big Pharma Advertising Getting Out of Control?

Short Sellers Become More Focused on Big Pharma

Short Sellers Back Off Big Pharma

Autoimmune Drugs to Drive Big Pharma Higher in Coming Years

New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels

3 Top Value Stock Picks to Buy for This Week

Short Sellers More Selective on Big Pharma Stocks

Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy

The 4 Stocks That Drove the DJIA Down on Wednesday

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts